These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24705350)

  • 1. UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency.
    Carriero MV; Bifulco K; Minopoli M; Lista L; Maglio O; Mele L; Di Carluccio G; De Rosa M; Pavone V
    Mol Cancer Ther; 2014 May; 13(5):1092-104. PubMed ID: 24705350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting.
    Bifulco K; Longanesi-Cattani I; Liguori E; Arra C; Rea D; Masucci MT; De Rosa M; Pavone V; Stoppelli MP; Carriero MV
    Mol Cancer Ther; 2013 Oct; 12(10):1981-93. PubMed ID: 23939376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.
    Carriero MV; Longanesi-Cattani I; Bifulco K; Maglio O; Lista L; Barbieri A; Votta G; Masucci MT; Arra C; Franco R; De Rosa M; Stoppelli MP; Pavone V
    Mol Cancer Ther; 2009 Sep; 8(9):2708-17. PubMed ID: 19706734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor.
    Bifulco K; Longanesi-Cattani I; Gargiulo L; Maglio O; Cataldi M; De Rosa M; Stoppelli MP; Pavone V; Carriero MV
    FEBS Lett; 2008 Apr; 582(7):1141-6. PubMed ID: 18339322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.
    Dal Monte M; Rezzola S; Cammalleri M; Belleri M; Locri F; Morbidelli L; Corsini M; Paganini G; Semeraro F; Cancarini A; Rusciano D; Presta M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2392-407. PubMed ID: 25766585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors.
    Nawaz IM; Chiodelli P; Rezzola S; Paganini G; Corsini M; Lodola A; Di Ianni A; Mor M; Presta M
    Angiogenesis; 2018 Feb; 21(1):47-59. PubMed ID: 29030736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
    Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
    Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
    Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.
    Minopoli M; Polo A; Ragone C; Ingangi V; Ciliberto G; Pessi A; Sarno S; Budillon A; Costantini S; Carriero MV
    Sci Rep; 2019 Aug; 9(1):12169. PubMed ID: 31434916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.
    Vicari D; Foy KC; Liotta EM; Kaumaya PT
    J Biol Chem; 2011 Apr; 286(15):13612-25. PubMed ID: 21321115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
    Koskimaki JE; Lee E; Chen W; Rivera CG; Rosca EV; Pandey NB; Popel AS
    Angiogenesis; 2013 Jan; 16(1):159-70. PubMed ID: 23053781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.
    Rezzola S; Corsini M; Chiodelli P; Cancarini A; Nawaz IM; Coltrini D; Mitola S; Ronca R; Belleri M; Lista L; Rusciano D; De Rosa M; Pavone V; Semeraro F; Presta M
    Diabetologia; 2017 Apr; 60(4):719-728. PubMed ID: 28083635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms Mediating Antiangiogenic Action of the Urokinase Receptor-Derived Peptide UPARANT in Human Retinal Endothelial Cells.
    Motta C; Lupo G; Rusciano D; Olivieri M; Lista L; De Rosa M; Pavone V; Anfuso CD
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5723-5735. PubMed ID: 27787560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3.
    Nawaz MI; Rezzola S; Tobia C; Coltrini D; Belleri M; Mitola S; Corsini M; Sandomenico A; Caporale A; Ruvo M; Presta M
    Angiogenesis; 2020 Aug; 23(3):357-369. PubMed ID: 32152757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IP-10 (CXCL10)-derived peptide inhibits angiogenesis.
    Yates-Binder CC; Rodgers M; Jaynes J; Wells A; Bodnar RJ; Turner T
    PLoS One; 2012; 7(7):e40812. PubMed ID: 22815829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
    Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis.
    Locri F; Dal Monte M; Aronsson M; Cammalleri M; De Rosa M; Pavone V; Kvanta A; Bagnoli P; André H
    J Mol Med (Berl); 2019 Sep; 97(9):1273-1283. PubMed ID: 31243519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activity.
    Kim JW; Kim TD; Hong BS; Kim OY; Yoon WH; Chae CB; Gho YS
    Exp Mol Med; 2010 Jul; 42(7):514-23. PubMed ID: 20543548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine inhibits angiogenesis through cytoskeleton remodeling.
    Pan L; Yu G; Huang J; Zheng X; Xu Y
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28864781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.